Carl Zeiss Meditec announced it has entered into an agreement to acquire IanTECH, the manufacturer of the miLOOP device for cataract surgery. miLOOP is a microinterventional device designed to deliver energy-free endocapsular lens fragmentation independent of phaco energy.
Terms of the deal were not disclosed.
Using micro-thin super-elastic, self expanding nitinol filament technology, the miLOOP device is designed to offer cataract surgeons the ability to achieve full thickness lens fragmentation for any grade cataract minimizing the intraocular ultrasonic vibrations and phaco power.
“We expect that IanTECH will complement our leading portfolio of equipment and consumables in cataract surgery, allowing us to offer physicians and patients a new standard of care,” Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec, said in a company news release. “The technology has the potential to simplify challenging cases, reduce risk to patients and further improve outcomes while being easy to train and adapt for surgeons.”
“We are pleased to bring the IanTECH team and technology into the Zeiss family,” said James V. Mazzo, Global President Ophthalmic Devices at Carl Zeiss Meditec.
“We look forward to joining Zeiss to combine our efforts in bringing superior technology to the market and we are pleased to align with the great culture and commitment at Zeiss,” adds Brian Walsh, CEO of IanTECH.